For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Op-Eds
Don’t Blame BPA on Lobster Decline
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Citation
USA – The billion dollar drug lobby in overdrive
Citation
Call Made for Continued Use of Antibiotics
Citation
CEI Backs Judicious Antimicrobial Use in Livestock
Comment
CEI Comments regarding FDA’s Draft Guidance on the Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
Executive Summary The Competitive Enterprise Institute respectfully submits these comments on the agency’s Draft Guidance on The Judicious Use of Medically Important Antimicrobial…
News Release
FDA Warned Against Hazards of Curtailing Antibiotic Use in Livestock
Washington, D.C., August 30, 2010 – The Competitive Enterprise Institute submitted comments today on an FDA proposal to limit the use of certain antibiotics in…